Reduce RSV Infections with Cleaner Air

Aura Air Inc. today announced the findings of an independent study confirming that the company's data-driven air purification devices are highly effective in eliminating the airborne pathogens that contribute to Respiratory Syncytial Virus (RSV).

A recent study by Innovative Bioanalysis Laboratory shows Aura Air's four-stage purification process filters and removes 99.997% of airborne RSV.

According to the U.S. Centers for Disease Control and Prevention, RSV results in approximately 58,000 annual hospitalizations.

Aura Air has partnered with schools, hospitals, and medical associations like the New Jersey Hospital Association (NJHA) to help them combat the spread of RSV, COVID-19, and the flu.

"Hospitals and communities across the country are being hit by an unprecedented surge in patients suffering from RSV, especially very young children," said New Jersey Hospital Association's SVP Michael A. Guerriero in a press release on January 4, 2023.

"Aura Air's advanced air purification and disinfection technology provide a welcome line of defense against these highly contagious viruses."

In addition to RSV, Sheba Medical Center, a leading Israeli medical facility, and Innovative Bioanalysis Laboratory confirmed that Aura Air successfully filters and removes 99.99% of airborne SARS-CoV-2 and 99.98% of Influenza A viruses.

Aura is headquartered in Israel with global offices in the U.S. and India, with distribution in about 87 countries.

Note: As of January 4, 2023, the U.S. FDA has not approved an RSV-preventive vaccine.

Disclosures: This content was sourced from the company and is not paid content.